The genetics of primary biliary cholangitis.


Journal

Current opinion in gastroenterology
ISSN: 1531-7056
Titre abrégé: Curr Opin Gastroenterol
Pays: United States
ID NLM: 8506887

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 3 1 2019
medline: 27 3 2020
entrez: 3 1 2019
Statut: ppublish

Résumé

Primary biliary cholangitis (PBC) is a female predominant chronic autoimmune disease of the intrahepatic bile ducts and with a long latent period. It is crucial to understand how genetics contribute to the disease. Geo-epidemiological studies in PBC have provided evidence of familial risk; case-control studies and genome wide association studies have identified various human leukocyte antigen (HLA) and non-HLA alleles that are associated with PBC. However, these alleles are non-PBC specific and most of the identified non-HLA loci were also found to be susceptible genes in other autoimmune diseases and different between study populations. Patients with PBC are often asymptomatic and often left undiagnosed. There are no known HLA and non-HLA alleles specific for PBC. Global effort and novel approaches such as epigenetics directed at identification of genetic risk factors will greatly facilitate accurate and timely diagnosis, which will improve prognosis and increase treatment options.

Identifiants

pubmed: 30601157
doi: 10.1097/MOG.0000000000000507
doi:

Substances chimiques

HLA Antigens 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

93-98

Auteurs

Atsushi Tanaka (A)

Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.

Patrick S C Leung (PSC)

Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.

Merrill Eric Gershwin (ME)

Division of Rheumatology Allergy and Clinical Immunology, University of California Davis School of Medicine, Davis, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH